Research output per year
Research output per year
- 11 results
Search results
-
2021
The BTK/PI3K/BRD4 axis inhibitor SRX3262 overcomes Ibrutinib resistance in mantle cell lymphoma
Pal, D., Vann, K. R., Joshi, S., Sahar, N. E., Morales, G. A., El-Gamal, D., Kutateladze, T. G. & Durden, D. L., Sep 24 2021, In: iScience. 24, 9, 102931.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
2019
Combinatorial Approach to Improve Cancer Immunotherapy: Rational Drug Design Strategy to Simultaneously Hit Multiple Targets to Kill Tumor Cells and to Activate the Immune System
Joshi, S. & Durden, D. L., 2019, In: Journal of Oncology. 2019, 5245034.Research output: Contribution to journal › Review article › peer-review
Open Access91 Scopus citations -
Erratum: Vascular permeability and remodelling coincide with inflammatory and reparative processes after joint bleeding in factor VIII-deficient mice (Thrombosis and Haemostasis (2018) 118:6 DOI: 10.1055/s-0038-1641755)
Cooke, E. J., Zhou, J. Y., Wyseure, T., Joshi, S., Bhat, V., Durden, D. L., Mosnier, L. O. & Von Drygalski, A., 2019, In: Thrombosis and Haemostasis. 119, 9, p. 1546 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
SF2523: Dual PI3K/BRD4 inhibitor blocks tumor immunosuppression and promotes adaptive immune responses in cancer
Joshi, S., Singh, A. R., Liu, K. X., Pham, T. V., Zulcic, M., Skola, D., Chun, H. B., Glass, C. K., Morales, G. A., Garlich, J. R. & Durden, D. L., 2019, In: Molecular cancer therapeutics. 18, 6, p. 1036-1044 9 p.Research output: Contribution to journal › Article › peer-review
Open Access40 Scopus citations -
2012
SF1126, a Pan-PI3K inhibitor has potent pre-clinical activity in aggressive B-cell non-Hodgkin lymphomas by inducing cell cycle arrest and apoptosis
Qi, W., Stejskal, A., Morales, C., Cooke, L. S., Garlich, J. R., Durden, D. & Mahadevan, D., 2012, In: Journal of Cancer Science and Therapy. 4, 7, p. 207-213 7 p.Research output: Contribution to journal › Article › peer-review
5 Scopus citations -
2006
'Pseudopalisading' necrosis in glioblastoma: A familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis
Rong, Y., Durden, D. L., Van Meir, E. G. & Brat, D. J., Jun 2006, In: Journal of Neuropathology and Experimental Neurology. 65, 6, p. 529-539 11 p.Research output: Contribution to journal › Review article › peer-review
446 Scopus citations -
2005
Cytokine expression and signaling in brain tumors
Dey, N., Durden, D. L. & Van Meir, E. G., Jan 1 2005, Cytokines and the CNS. CRC Press, p. 194-242 49 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter
2 Scopus citations -
2002
SHP-1 regulates Fcγ receptor-mediated phagocytosis and the activation of RAC
Kant, A. M., De, P., Peng, X., Yi, T., Rawlings, D. J., Kim, J. S. & Durden, D. L., Sep 1 2002, In: Blood. 100, 5, p. 1852-1859 8 p.Research output: Contribution to journal › Article › peer-review
64 Scopus citations -
2001
Plasminogen activator inhibitor-1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin
Isogai, C., Laug, W. E., Shimada, H., Declerck, P. J., Stins, M. F., Durden, D. L., Erdreich-Epstein, A. & DeClerck, Y. A., Jul 15 2001, In: Cancer Research. 61, 14, p. 5587-5594 8 p.Research output: Contribution to journal › Article › peer-review
160 Scopus citations -
1995
The FcγRI receptor signals through the activation of hck and MAP kinase
Durden, D. L., Hwang Min Kim, M. K., Calore, B. & Liu, Y., 1995, In: Journal of Immunology. 154, 8, p. 4039-4047 9 p.Research output: Contribution to journal › Article › peer-review
93 Scopus citations -
1982
Vibrio succinogenes asparaginase: An antilymphoma agent lacking hepatotoxicity
Durden, D. L., Salazar, A. M., Nadji, M. & Distasio, J. A., 1982, In: Proceedings of the American Association for Cancer Research. Vol. 23, p. No. 805Research output: Contribution to journal › Article › peer-review